Updates and Considerations for the Multidisciplinary Management of Breast Cancer Through the COVID-19 Pandemic

This OncLive^® webinar will focus on the impact of COVID-19 in patients with breast cancer and the innovative ways in which treatment has evolved during this time. We will feature a panel of experts from Dana-Farber Cancer Institute led by Eric P. Winer, MD, to discuss important topics and key information for treating patients with breast cancer.

Topics/Objectives:

• Risk of patients with breast cancer for developing COVID-19
• Best practices in the management of patients with breast cancer that have the novel coronavirus or who may be at risk for developing it
• Expanding use of telemedicine in breast cancer care
• Impact the COVID-19 pandemic has had on testing in patients with breast cancer

Novartis

Dana-Farber Cancer Institute